로딩 중…
지수 로딩 중…
Madrigal Pharmaceuticals, Inc.
MDGL· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$505.75+1.18%
2026-06-18
Price Chart
Madrigal Pharmaceuticals, Inc.+78.89%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $11.66B |
| Revenue | $1.13B |
| Net Income | $-309M |
| Total Assets | $1.23B |
| Net Assets | $543M |
| Value | |
| P/B | 21.46x |
| P/S | 10.30x |
| FCF Yield | -2.34% |
| Profitability | |
| ROE | -56.94% |
| ROA | -25.21% |
| Op. Margin | -27.68% |
| Revenue Growth | 126.84% |
| Financial Health | |
| Debt Ratio | 125.84% |
| Total Debt | $347M |
| FCF | $-272M |
| Cash | $232M |
| Current Ratio | 3.50x |
| Performance | |
| 1Y Return | 78.89% |
| 1M Return | -1.19% |
| From 52W High | -17.76% |
| 1Y MDD | -29.36% |
| Trading | |
| Volume | 446,202 shares |
| Trading Value | $224M |
| Per Share | |
| EPS | $-12.85 |
| BPS | $26.86 |